HER2-targeted therapies — a role beyond breast cancer | Nature Reviews Clinical Oncology
Mechanisms of resistance and sensitivity to anti-HER2 therapies in HER2+ breast cancer | Oncotarget
References in Evolving novel anti-HER2 strategies - The Lancet Oncology
Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes - ScienceDirect
Targeted therapeutic options and future perspectives for HER2-positive breast cancer | Signal Transduction and Targeted Therapy
How PERJETA® (pertuzumab) works for HER2+ Breast Cancer | HCP
Pertuzumab Overview - Creative Biolabs
How PERJETA® (pertuzumab) works for HER2+ Breast Cancer | HCP
Toxicology of Trastuzumab: An Insight into Mechanisms of Cardiotoxicity | Bentham Science
Trastuzumab — Mechanism of Action and Use in Clinical Practice | NEJM
Pertuzumab: Development Beyond Breast Cancer | Anticancer Research
Trastuzumab Emtansine: Mechanisms of Action and Resistance, Clinical Progress, and Beyond: Trends in Cancer
Structural insights into the mechanism of action of a biparatopic anti-HER2 antibody - Journal of Biological Chemistry
Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silicobased mechanism | Breast Cancer Research | Full Text
Pertuzumab - Wikipedia
Pertuzumab in human epidermal growth-factor receptor 2-positive breast | IJWH
Interaction of host immunity with HER2-targeted treatment and tumor heterogeneity in HER2-positive breast cancer | Journal for ImmunoTherapy of Cancer
Precision medicine and personalized breast cancer: combination pertuzu | PGPM
Cancers | Free Full-Text | Mechanisms Underlying the Action and Synergism of Trastuzumab and Pertuzumab in Targeting HER2-Positive Breast Cancer
Anti-HER2 therapy in metastatic breast cancer: many choices and future directions | SpringerLink
Emerging approaches for treating HER2-positive metastatic breast cancer beyond trastuzumab - Annals of Oncology
Pertuzumab in HER2-positive early breast cancer: current use and perspectives | Future Oncology
